医療用ヘパリンのグローバル市場予測2023-2029

◆英語タイトル:Global Medical Heparin Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23OT8791)◆商品コード:LP23OT8791
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年10月
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「医療用ヘパリンのグローバル市場」は、過去の販売実績から2022年の世界の医療用ヘパリンの総販売量を検討し、2023年から2029年の予測される医療用ヘパリンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医療用ヘパリンの市場規模を掲載し、XXX百万米ドル規模の世界の医療用ヘパリン市場の詳細な分析を提供します。本インサイトレポートは、世界の医療用ヘパリン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の医療用ヘパリン市場における各社の独自のポジションをより深く理解するために、医療用ヘパリン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の医療用ヘパリン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医療用ヘパリンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。医療用ヘパリンの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医療用ヘパリンのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

医療用ヘパリンの世界主要メーカーとしては、Hepalink、 Changshan Pharm、 Pfizer、 Bioberica、 Criticine Care、 SmithField BioScience、 Sanofi、 Fresenius Kabi、 Aspen Pharmacare、 LEO Pharma、 Baxter Healthcare、 Cardinal Health、 SwissPAR、 Fierce Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の医療用ヘパリン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では医療用ヘパリン市場をセグメンテーションし、種類別 (高分子量ヘパリン(HMWH)、低分子量ヘパリン(LMWH))、用途別 (血栓性疾患治療、術後リハビリテーション、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:高分子量ヘパリン(HMWH)、低分子量ヘパリン(LMWH)

・用途別区分:血栓性疾患治療、術後リハビリテーション、その他

・地域別区分
南北アメリカ(米国、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の医療用ヘパリン市場の10年間の市場状況・展望は?
・世界および地域別に見た医療用ヘパリン市場成長の要因は何か?
・医療用ヘパリンの市場機会はエンドマーケットの規模によってどのように変化するのか?
・医療用ヘパリンのタイプ別、用途別の内訳は?
・新型コロナウイルスとロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:医療用ヘパリンの年間販売量2018-2029、地域別現状・将来分析
・医療用ヘパリンの種類別セグメント:高分子量ヘパリン(HMWH)、低分子量ヘパリン(LMWH)
・医療用ヘパリンの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・医療用ヘパリンの用途別セグメント:血栓性疾患治療、術後リハビリテーション、その他
・医療用ヘパリンの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の医療用ヘパリン市場
・企業別のグローバル医療用ヘパリン市場データ:2018-2023年の年間販売量、市場シェア
・企業別の医療用ヘパリンの年間売上:2018-2023年の売上、市場シェア
・企業別の医療用ヘパリン販売価格
・主要企業の医療用ヘパリン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

医療用ヘパリンの地域別レビュー
・地域別の医療用ヘパリン市場規模2018-2023:年間販売量、売上
・主要国別の医療用ヘパリン市場規模2018-2023:年間販売量、売上
・南北アメリカの医療用ヘパリン販売の成長
・アジア太平洋の医療用ヘパリン販売の成長
・ヨーロッパの医療用ヘパリン販売の成長
・中東・アフリカの医療用ヘパリン販売の成長

南北アメリカ市場
・南北アメリカの国別の医療用ヘパリン販売量、売上(2018-2023)
・南北アメリカの医療用ヘパリンの種類別販売量
・南北アメリカの医療用ヘパリンの用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の医療用ヘパリン販売量、売上(2018-2023)
・アジア太平洋の医療用ヘパリンの種類別販売量
・アジア太平洋の医療用ヘパリンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の医療用ヘパリン販売量、売上(2018-2023)
・ヨーロッパの医療用ヘパリンの種類別販売量
・ヨーロッパの医療用ヘパリンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の医療用ヘパリン販売量、売上(2018-2023)
・中東・アフリカの医療用ヘパリンの種類別販売量
・中東・アフリカの医療用ヘパリンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・医療用ヘパリンの製造コスト構造分析
・医療用ヘパリンの製造プロセス分析
・医療用ヘパリンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・医療用ヘパリンの主要なグローバル販売業者
・医療用ヘパリンの主要なグローバル顧客

地域別の医療用ヘパリン市場予測レビュー
・地域別の医療用ヘパリン市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・医療用ヘパリンの種類別市場規模予測
・医療用ヘパリンの用途別市場規模予測

主要企業分析
Hepalink、 Changshan Pharm、 Pfizer、 Bioberica、 Criticine Care、 SmithField BioScience、 Sanofi、 Fresenius Kabi、 Aspen Pharmacare、 LEO Pharma、 Baxter Healthcare、 Cardinal Health、 SwissPAR、 Fierce Pharma
・企業情報
・医療用ヘパリン製品
・医療用ヘパリン販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Heparin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Medical Heparin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Medical Heparin by Country/Region, 2018, 2022 & 2029
2.2 Medical Heparin Segment by Molecular Weight
2.2.1 High Molecular Weight Heparin (HMWH)
2.2.2 Low Molecular Weight Heparin (LMWH)
2.3 Medical Heparin Sales by Molecular Weight
2.3.1 Global Medical Heparin Sales Market Share by Molecular Weight (2018-2023)
2.3.2 Global Medical Heparin Revenue and Market Share by Molecular Weight (2018-2023)
2.3.3 Global Medical Heparin Sale Price by Molecular Weight (2018-2023)
2.4 Medical Heparin Segment by Application
2.4.1 Treatment of Thrombotic Diseases
2.4.2 Postoperative Rehabilitation
2.4.3 Others
2.5 Medical Heparin Sales by Application
2.5.1 Global Medical Heparin Sale Market Share by Application (2018-2023)
2.5.2 Global Medical Heparin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Medical Heparin Sale Price by Application (2018-2023)
3 Global Medical Heparin by Company
3.1 Global Medical Heparin Breakdown Data by Company
3.1.1 Global Medical Heparin Annual Sales by Company (2018-2023)
3.1.2 Global Medical Heparin Sales Market Share by Company (2018-2023)
3.2 Global Medical Heparin Annual Revenue by Company (2018-2023)
3.2.1 Global Medical Heparin Revenue by Company (2018-2023)
3.2.2 Global Medical Heparin Revenue Market Share by Company (2018-2023)
3.3 Global Medical Heparin Sale Price by Company
3.4 Key Manufacturers Medical Heparin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Heparin Product Location Distribution
3.4.2 Players Medical Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Medical Heparin by Geographic Region
4.1 World Historic Medical Heparin Market Size by Geographic Region (2018-2023)
4.1.1 Global Medical Heparin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Medical Heparin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Medical Heparin Market Size by Country/Region (2018-2023)
4.2.1 Global Medical Heparin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Medical Heparin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Medical Heparin Sales Growth
4.4 APAC Medical Heparin Sales Growth
4.5 Europe Medical Heparin Sales Growth
4.6 Middle East & Africa Medical Heparin Sales Growth
5 Americas
5.1 Americas Medical Heparin Sales by Country
5.1.1 Americas Medical Heparin Sales by Country (2018-2023)
5.1.2 Americas Medical Heparin Revenue by Country (2018-2023)
5.2 Americas Medical Heparin Sales by Molecular Weight
5.3 Americas Medical Heparin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Heparin Sales by Region
6.1.1 APAC Medical Heparin Sales by Region (2018-2023)
6.1.2 APAC Medical Heparin Revenue by Region (2018-2023)
6.2 APAC Medical Heparin Sales by Molecular Weight
6.3 APAC Medical Heparin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Heparin by Country
7.1.1 Europe Medical Heparin Sales by Country (2018-2023)
7.1.2 Europe Medical Heparin Revenue by Country (2018-2023)
7.2 Europe Medical Heparin Sales by Molecular Weight
7.3 Europe Medical Heparin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Heparin by Country
8.1.1 Middle East & Africa Medical Heparin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Medical Heparin Revenue by Country (2018-2023)
8.2 Middle East & Africa Medical Heparin Sales by Molecular Weight
8.3 Middle East & Africa Medical Heparin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Heparin
10.3 Manufacturing Process Analysis of Medical Heparin
10.4 Industry Chain Structure of Medical Heparin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Heparin Distributors
11.3 Medical Heparin Customer
12 World Forecast Review for Medical Heparin by Geographic Region
12.1 Global Medical Heparin Market Size Forecast by Region
12.1.1 Global Medical Heparin Forecast by Region (2024-2029)
12.1.2 Global Medical Heparin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Medical Heparin Forecast by Molecular Weight
12.7 Global Medical Heparin Forecast by Application
13 Key Players Analysis
13.1 Hepalink
13.1.1 Hepalink Company Information
13.1.2 Hepalink Medical Heparin Product Portfolios and Specifications
13.1.3 Hepalink Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hepalink Main Business Overview
13.1.5 Hepalink Latest Developments
13.2 Changshan Pharm
13.2.1 Changshan Pharm Company Information
13.2.2 Changshan Pharm Medical Heparin Product Portfolios and Specifications
13.2.3 Changshan Pharm Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Changshan Pharm Main Business Overview
13.2.5 Changshan Pharm Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Medical Heparin Product Portfolios and Specifications
13.3.3 Pfizer Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Bioberica
13.4.1 Bioberica Company Information
13.4.2 Bioberica Medical Heparin Product Portfolios and Specifications
13.4.3 Bioberica Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bioberica Main Business Overview
13.4.5 Bioberica Latest Developments
13.5 Criticine Care
13.5.1 Criticine Care Company Information
13.5.2 Criticine Care Medical Heparin Product Portfolios and Specifications
13.5.3 Criticine Care Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Criticine Care Main Business Overview
13.5.5 Criticine Care Latest Developments
13.6 SmithField BioScience
13.6.1 SmithField BioScience Company Information
13.6.2 SmithField BioScience Medical Heparin Product Portfolios and Specifications
13.6.3 SmithField BioScience Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 SmithField BioScience Main Business Overview
13.6.5 SmithField BioScience Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Medical Heparin Product Portfolios and Specifications
13.7.3 Sanofi Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Medical Heparin Product Portfolios and Specifications
13.8.3 Fresenius Kabi Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Aspen Pharmacare
13.9.1 Aspen Pharmacare Company Information
13.9.2 Aspen Pharmacare Medical Heparin Product Portfolios and Specifications
13.9.3 Aspen Pharmacare Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Aspen Pharmacare Main Business Overview
13.9.5 Aspen Pharmacare Latest Developments
13.10 LEO Pharma
13.10.1 LEO Pharma Company Information
13.10.2 LEO Pharma Medical Heparin Product Portfolios and Specifications
13.10.3 LEO Pharma Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 LEO Pharma Main Business Overview
13.10.5 LEO Pharma Latest Developments
13.11 Baxter Healthcare
13.11.1 Baxter Healthcare Company Information
13.11.2 Baxter Healthcare Medical Heparin Product Portfolios and Specifications
13.11.3 Baxter Healthcare Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Baxter Healthcare Main Business Overview
13.11.5 Baxter Healthcare Latest Developments
13.12 Cardinal Health
13.12.1 Cardinal Health Company Information
13.12.2 Cardinal Health Medical Heparin Product Portfolios and Specifications
13.12.3 Cardinal Health Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Cardinal Health Main Business Overview
13.12.5 Cardinal Health Latest Developments
13.13 SwissPAR
13.13.1 SwissPAR Company Information
13.13.2 SwissPAR Medical Heparin Product Portfolios and Specifications
13.13.3 SwissPAR Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 SwissPAR Main Business Overview
13.13.5 SwissPAR Latest Developments
13.14 Fierce Pharma
13.14.1 Fierce Pharma Company Information
13.14.2 Fierce Pharma Medical Heparin Product Portfolios and Specifications
13.14.3 Fierce Pharma Medical Heparin Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Fierce Pharma Main Business Overview
13.14.5 Fierce Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Medical Heparin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Medical Heparin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of High Molecular Weight Heparin (HMWH)
Table 4. Major Players of Low Molecular Weight Heparin (LMWH)
Table 5. Global Medical Heparin Sales by Molecular Weight (2018-2023) & (Tons)
Table 6. Global Medical Heparin Sales Market Share by Molecular Weight (2018-2023)
Table 7. Global Medical Heparin Revenue by Molecular Weight (2018-2023) & ($ million)
Table 8. Global Medical Heparin Revenue Market Share by Molecular Weight (2018-2023)
Table 9. Global Medical Heparin Sale Price by Molecular Weight (2018-2023) & (US$/Ton)
Table 10. Global Medical Heparin Sales by Application (2018-2023) & (Tons)
Table 11. Global Medical Heparin Sales Market Share by Application (2018-2023)
Table 12. Global Medical Heparin Revenue by Application (2018-2023)
Table 13. Global Medical Heparin Revenue Market Share by Application (2018-2023)
Table 14. Global Medical Heparin Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Medical Heparin Sales by Company (2018-2023) & (Tons)
Table 16. Global Medical Heparin Sales Market Share by Company (2018-2023)
Table 17. Global Medical Heparin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Medical Heparin Revenue Market Share by Company (2018-2023)
Table 19. Global Medical Heparin Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Medical Heparin Producing Area Distribution and Sales Area
Table 21. Players Medical Heparin Products Offered
Table 22. Medical Heparin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Medical Heparin Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Medical Heparin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Medical Heparin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Medical Heparin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Medical Heparin Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Medical Heparin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Medical Heparin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Medical Heparin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Medical Heparin Sales by Country (2018-2023) & (Tons)
Table 34. Americas Medical Heparin Sales Market Share by Country (2018-2023)
Table 35. Americas Medical Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Medical Heparin Revenue Market Share by Country (2018-2023)
Table 37. Americas Medical Heparin Sales by Type (2018-2023) & (Tons)
Table 38. Americas Medical Heparin Sales by Application (2018-2023) & (Tons)
Table 39. APAC Medical Heparin Sales by Region (2018-2023) & (Tons)
Table 40. APAC Medical Heparin Sales Market Share by Region (2018-2023)
Table 41. APAC Medical Heparin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Medical Heparin Revenue Market Share by Region (2018-2023)
Table 43. APAC Medical Heparin Sales by Molecular Weight (2018-2023) & (Tons)
Table 44. APAC Medical Heparin Sales by Application (2018-2023) & (Tons)
Table 45. Europe Medical Heparin Sales by Country (2018-2023) & (Tons)
Table 46. Europe Medical Heparin Sales Market Share by Country (2018-2023)
Table 47. Europe Medical Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Medical Heparin Revenue Market Share by Country (2018-2023)
Table 49. Europe Medical Heparin Sales by Type (2018-2023) & (Tons)
Table 50. Europe Medical Heparin Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Medical Heparin Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Medical Heparin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Medical Heparin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Medical Heparin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Medical Heparin Sales by Molecular Weight (2018-2023) & (Tons)
Table 56. Middle East & Africa Medical Heparin Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Medical Heparin
Table 58. Key Market Challenges & Risks of Medical Heparin
Table 59. Key Industry Trends of Medical Heparin
Table 60. Medical Heparin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Medical Heparin Distributors List
Table 63. Medical Heparin Customer List
Table 64. Global Medical Heparin Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Medical Heparin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Medical Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Medical Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Medical Heparin Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Medical Heparin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Medical Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Medical Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Medical Heparin Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Medical Heparin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Medical Heparin Sales Forecast by Molecular Weight (2024-2029) & (Tons)
Table 75. Global Medical Heparin Revenue Forecast by Molecular Weight (2024-2029) & ($ Millions)
Table 76. Global Medical Heparin Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Medical Heparin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Hepalink Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 79. Hepalink Medical Heparin Product Portfolios and Specifications
Table 80. Hepalink Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Hepalink Main Business
Table 82. Hepalink Latest Developments
Table 83. Changshan Pharm Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 84. Changshan Pharm Medical Heparin Product Portfolios and Specifications
Table 85. Changshan Pharm Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Changshan Pharm Main Business
Table 87. Changshan Pharm Latest Developments
Table 88. Pfizer Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Medical Heparin Product Portfolios and Specifications
Table 90. Pfizer Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Bioberica Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 94. Bioberica Medical Heparin Product Portfolios and Specifications
Table 95. Bioberica Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Bioberica Main Business
Table 97. Bioberica Latest Developments
Table 98. Criticine Care Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 99. Criticine Care Medical Heparin Product Portfolios and Specifications
Table 100. Criticine Care Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Criticine Care Main Business
Table 102. Criticine Care Latest Developments
Table 103. SmithField BioScience Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 104. SmithField BioScience Medical Heparin Product Portfolios and Specifications
Table 105. SmithField BioScience Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. SmithField BioScience Main Business
Table 107. SmithField BioScience Latest Developments
Table 108. Sanofi Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Medical Heparin Product Portfolios and Specifications
Table 110. Sanofi Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. Fresenius Kabi Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 114. Fresenius Kabi Medical Heparin Product Portfolios and Specifications
Table 115. Fresenius Kabi Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Fresenius Kabi Main Business
Table 117. Fresenius Kabi Latest Developments
Table 118. Aspen Pharmacare Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 119. Aspen Pharmacare Medical Heparin Product Portfolios and Specifications
Table 120. Aspen Pharmacare Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Aspen Pharmacare Main Business
Table 122. Aspen Pharmacare Latest Developments
Table 123. LEO Pharma Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 124. LEO Pharma Medical Heparin Product Portfolios and Specifications
Table 125. LEO Pharma Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. LEO Pharma Main Business
Table 127. LEO Pharma Latest Developments
Table 128. Baxter Healthcare Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 129. Baxter Healthcare Medical Heparin Product Portfolios and Specifications
Table 130. Baxter Healthcare Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Baxter Healthcare Main Business
Table 132. Baxter Healthcare Latest Developments
Table 133. Cardinal Health Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 134. Cardinal Health Medical Heparin Product Portfolios and Specifications
Table 135. Cardinal Health Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Cardinal Health Main Business
Table 137. Cardinal Health Latest Developments
Table 138. SwissPAR Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 139. SwissPAR Medical Heparin Product Portfolios and Specifications
Table 140. SwissPAR Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. SwissPAR Main Business
Table 142. SwissPAR Latest Developments
Table 143. Fierce Pharma Basic Information, Medical Heparin Manufacturing Base, Sales Area and Its Competitors
Table 144. Fierce Pharma Medical Heparin Product Portfolios and Specifications
Table 145. Fierce Pharma Medical Heparin Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Fierce Pharma Main Business
Table 147. Fierce Pharma Latest Developments
List of Figures
Figure 1. Picture of Medical Heparin
Figure 2. Medical Heparin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Heparin Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Medical Heparin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Medical Heparin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of High Molecular Weight Heparin (HMWH)
Figure 10. Product Picture of Low Molecular Weight Heparin (LMWH)
Figure 11. Global Medical Heparin Sales Market Share by Molecular Weight in 2022
Figure 12. Global Medical Heparin Revenue Market Share by Molecular Weight (2018-2023)
Figure 13. Medical Heparin Consumed in Treatment of Thrombotic Diseases
Figure 14. Global Medical Heparin Market: Treatment of Thrombotic Diseases (2018-2023) & (Tons)
Figure 15. Medical Heparin Consumed in Postoperative Rehabilitation
Figure 16. Global Medical Heparin Market: Postoperative Rehabilitation (2018-2023) & (Tons)
Figure 17. Medical Heparin Consumed in Others
Figure 18. Global Medical Heparin Market: Others (2018-2023) & (Tons)
Figure 19. Global Medical Heparin Sales Market Share by Application (2022)
Figure 20. Global Medical Heparin Revenue Market Share by Application in 2022
Figure 21. Medical Heparin Sales Market by Company in 2022 (Tons)
Figure 22. Global Medical Heparin Sales Market Share by Company in 2022
Figure 23. Medical Heparin Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Medical Heparin Revenue Market Share by Company in 2022
Figure 25. Global Medical Heparin Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Medical Heparin Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Medical Heparin Sales 2018-2023 (Tons)
Figure 28. Americas Medical Heparin Revenue 2018-2023 ($ Millions)
Figure 29. APAC Medical Heparin Sales 2018-2023 (Tons)
Figure 30. APAC Medical Heparin Revenue 2018-2023 ($ Millions)
Figure 31. Europe Medical Heparin Sales 2018-2023 (Tons)
Figure 32. Europe Medical Heparin Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Medical Heparin Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Medical Heparin Revenue 2018-2023 ($ Millions)
Figure 35. Americas Medical Heparin Sales Market Share by Country in 2022
Figure 36. Americas Medical Heparin Revenue Market Share by Country in 2022
Figure 37. Americas Medical Heparin Sales Market Share by Molecular Weight (2018-2023)
Figure 38. Americas Medical Heparin Sales Market Share by Application (2018-2023)
Figure 39. United States Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Medical Heparin Sales Market Share by Region in 2022
Figure 44. APAC Medical Heparin Revenue Market Share by Regions in 2022
Figure 45. APAC Medical Heparin Sales Market Share by Molecular Weight (2018-2023)
Figure 46. APAC Medical Heparin Sales Market Share by Application (2018-2023)
Figure 47. China Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Medical Heparin Sales Market Share by Country in 2022
Figure 55. Europe Medical Heparin Revenue Market Share by Country in 2022
Figure 56. Europe Medical Heparin Sales Market Share by Molecular Weight (2018-2023)
Figure 57. Europe Medical Heparin Sales Market Share by Application (2018-2023)
Figure 58. Germany Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Medical Heparin Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Medical Heparin Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Medical Heparin Sales Market Share by Molecular Weight (2018-2023)
Figure 66. Middle East & Africa Medical Heparin Sales Market Share by Application (2018-2023)
Figure 67. Egypt Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Medical Heparin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Medical Heparin in 2022
Figure 73. Manufacturing Process Analysis of Medical Heparin
Figure 74. Industry Chain Structure of Medical Heparin
Figure 75. Channels of Distribution
Figure 76. Global Medical Heparin Sales Market Forecast by Region (2024-2029)
Figure 77. Global Medical Heparin Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Medical Heparin Sales Market Share Forecast by Molecular Weight (2024-2029)
Figure 79. Global Medical Heparin Revenue Market Share Forecast by Molecular Weight (2024-2029)
Figure 80. Global Medical Heparin Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Medical Heparin Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療用ヘパリンのグローバル市場予測2023-2029(Global Medical Heparin Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆